Cargando…

Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment

Detalles Bibliográficos
Autores principales: Gisondi, Paolo, Zaza, Gianluigi, Del Giglio, Micol, Rossi, Mattia, Iacono, Valentina, Girolomoni, Giampiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194926/
https://www.ncbi.nlm.nih.gov/pubmed/32330632
http://dx.doi.org/10.1016/j.jaad.2020.04.085
_version_ 1783528432273981440
author Gisondi, Paolo
Zaza, Gianluigi
Del Giglio, Micol
Rossi, Mattia
Iacono, Valentina
Girolomoni, Giampiero
author_facet Gisondi, Paolo
Zaza, Gianluigi
Del Giglio, Micol
Rossi, Mattia
Iacono, Valentina
Girolomoni, Giampiero
author_sort Gisondi, Paolo
collection PubMed
description
format Online
Article
Text
id pubmed-7194926
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-71949262020-05-02 Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment Gisondi, Paolo Zaza, Gianluigi Del Giglio, Micol Rossi, Mattia Iacono, Valentina Girolomoni, Giampiero J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2020-07 2020-04-21 /pmc/articles/PMC7194926/ /pubmed/32330632 http://dx.doi.org/10.1016/j.jaad.2020.04.085 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Gisondi, Paolo
Zaza, Gianluigi
Del Giglio, Micol
Rossi, Mattia
Iacono, Valentina
Girolomoni, Giampiero
Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
title Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
title_full Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
title_fullStr Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
title_full_unstemmed Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
title_short Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
title_sort risk of hospitalization and death from covid-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194926/
https://www.ncbi.nlm.nih.gov/pubmed/32330632
http://dx.doi.org/10.1016/j.jaad.2020.04.085
work_keys_str_mv AT gisondipaolo riskofhospitalizationanddeathfromcovid19infectioninpatientswithchronicplaquepsoriasisreceivingabiologictreatmentandrenaltransplantrecipientsinmaintenanceimmunosuppressivetreatment
AT zazagianluigi riskofhospitalizationanddeathfromcovid19infectioninpatientswithchronicplaquepsoriasisreceivingabiologictreatmentandrenaltransplantrecipientsinmaintenanceimmunosuppressivetreatment
AT delgigliomicol riskofhospitalizationanddeathfromcovid19infectioninpatientswithchronicplaquepsoriasisreceivingabiologictreatmentandrenaltransplantrecipientsinmaintenanceimmunosuppressivetreatment
AT rossimattia riskofhospitalizationanddeathfromcovid19infectioninpatientswithchronicplaquepsoriasisreceivingabiologictreatmentandrenaltransplantrecipientsinmaintenanceimmunosuppressivetreatment
AT iaconovalentina riskofhospitalizationanddeathfromcovid19infectioninpatientswithchronicplaquepsoriasisreceivingabiologictreatmentandrenaltransplantrecipientsinmaintenanceimmunosuppressivetreatment
AT girolomonigiampiero riskofhospitalizationanddeathfromcovid19infectioninpatientswithchronicplaquepsoriasisreceivingabiologictreatmentandrenaltransplantrecipientsinmaintenanceimmunosuppressivetreatment